- Home
- FEAM vs MBRX Comparison
FEAM vs MBRX Comparison
Compare FEAM & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEAM
- MBRX
- Stock Information
- Founded
- FEAM 2016
- MBRX 2015
- Country
- FEAM United States
- MBRX United States
- Employees
- FEAM N/A
- MBRX N/A
- Industry
- FEAM Major Chemicals
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- FEAM Industrials
- MBRX Health Care
- Exchange
- FEAM Nasdaq
- MBRX Nasdaq
- Market Cap
- FEAM 12.8M
- MBRX 12.9M
- IPO Year
- FEAM N/A
- MBRX 2016
- Fundamental
- Price
- FEAM $3.51
- MBRX $0.31
- Analyst Decision
- FEAM Strong Buy
- MBRX Strong Buy
- Analyst Count
- FEAM 2
- MBRX 3
- Target Price
- FEAM $121.00
- MBRX $5.33
- AVG Volume (30 Days)
- FEAM 11.9K
- MBRX 5.2M
- Earning Date
- FEAM 05-15-2025
- MBRX 08-13-2025
- Dividend Yield
- FEAM N/A
- MBRX N/A
- EPS Growth
- FEAM N/A
- MBRX N/A
- EPS
- FEAM N/A
- MBRX N/A
- Revenue
- FEAM N/A
- MBRX N/A
- Revenue This Year
- FEAM N/A
- MBRX N/A
- Revenue Next Year
- FEAM N/A
- MBRX N/A
- P/E Ratio
- FEAM N/A
- MBRX N/A
- Revenue Growth
- FEAM N/A
- MBRX N/A
- 52 Week Low
- FEAM $2.82
- MBRX $0.25
- 52 Week High
- FEAM $33.81
- MBRX $4.71
- Technical
- Relative Strength Index (RSI)
- FEAM 33.46
- MBRX 24.39
- Support Level
- FEAM $3.41
- MBRX $0.25
- Resistance Level
- FEAM $3.85
- MBRX $0.42
- Average True Range (ATR)
- FEAM 0.28
- MBRX 0.06
- MACD
- FEAM -0.06
- MBRX -0.03
- Stochastic Oscillator
- FEAM 15.24
- MBRX 13.07
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.